ATORX — Alligator Bioscience AB Share News
0.000.00%
- SEK89.83m
- SEK103.14m
- SEK0.51m
Brief: Alligator Bioscience Q4 Net Sales At SEK 5.2 Mln
Brief: Alligator Starts Research Deal With University Of Pennsylvania
Brief: Alligator Bioscience Announces Optimize-1 Trial Update; Cohort Fully Dosed With No Adverse Effects Reported
Brief: Alligator Bioscience Announces Trial Update
Brief: Alligator Announces Final Outcome Of Rights Issue
Brief: Alligator Announces Preliminary Outcome Of Rights Issue
Brief: Alligator Operating Loss Widens To SEK 37.7 Mln
Brief: Alligator Bioscience Carries Out A 100% Secured Rights Issue Of About SEK 257 Million
Brief: Alligator Is Exploring Financing Alternatives
Brief: Scandion And Alligator Bioscience Announce Positive Results From Collaboration
Brief: Orion Corporation And Alligator Bioscience Enter Research Agreement
Brief: Alligator Bioscience And Orion Corporation Enter Research Agreement
Brief: Alligator Bioscience Q2 Operating Loss At SEK 34.5 Mln
Brief: Alligator Bioscience And Scandion Oncology Present Promising Preclinical Data
Brief: Alligator Bioscience And BioArctic Enter Into Research Collaboration
Brief: Alligator Bioscience Q1 Operating Loss Narrows To SEK 32.5 Mln
Brief: Alligator Bioscience Names Anders Ekblom Chairman Of Board
Brief: Alligator Bioscience And MacroGenics Enter Into Research Collaboration
Brief: Alligator Bioscience Postpones The Annual General Meeting To June 1, 2021